NIH, in collaboration with the Administration for Strategic Preparedness and Response at HHS, has launched the Home Test to Treat program, an entirely virtual community health intervention that will provide free COVID-19 health services—at-home rapid tests, telehealth sessions and at-home treatments—in selected communities.
There are so many unknowns about long COVID. Why is the range of symptoms so vast? How do pre-existing conditions play a role? Scientists have developed a machine learning tool to accelerate discoveries using actual patient data.
As we dive deep into a new wave of COVID-19 infections this winter, the value of masking is back in public discourse.
The long-term effects of infection on the immune system have long intrigued John Tsang, a Yale immunobiologist. After the body has faced down a pathogen, does the immune system return to the previous baseline? Or does a single infection change it in ways that alter how it will respond not only to a familiar virus but also to the next new viral or bacterial threat it faces?
Breaking research demonstrates the efficacy of two data analytics-based strategies that clinical labs employed to meet COVID-19 testing demands during the height of the pandemic. These findings, published in the Data Science Issue of AACC’s The Journal of Applied Laboratory Medicine, give labs a blueprint for using data analytics to ensure patient access to testing during future infectious disease outbreaks.
Risk of severe COVID-19 continues to outweigh rare risk of post-vaccination myocarditis
Recent evidence has emerged to suggest that age-related macular degeneration (AMD) is a clinical risk factor for increased risk for infection and mortality.
In this study of study of 385 patients ages 5 or older with a history of multisystem inflammatory syndrome in children (MIS-C), no serious adverse events were reported after COVID-19 vaccination.
Recent evidence has emerged to suggest that age-related macular degeneration (AMD) is a clinical risk factor for increased risk for infection and mortality.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.
A research team that studied Juneau’s early response to the pandemic has identified a number of factors that helped the Alaskan capital mitigate COVID-19’s impact on residents.
The study, published in the European Journal of Public Health, is based on data concerning 25,049 children aged three to five who have undergone regular health checks at child health centers.
New research from the University of Virginia School of Medicine speaks to the benefits of a COVID-19 booster.
Researchers at the University of Houston Conrad N. Hilton College of Global Hospitality Leadership say many skilled hospitality workers who were furloughed or laid off during the COVID-19 pandemic are angry and unlikely to return to the industry.
The American Society of Anesthesiologists (ASA) and the Anesthesia Patient Safety Foundation (APSF) today updated their advice to recommend against routine, universal COVID-19 testing before procedures and surgery in asymptomatic patients. The updated statement – revising previous guidance – supports a Society for Healthcare Epidemiology of America (SHEA) commentary published in December 2022.
“A ZIP code should not determine the life expectancy nor the diseases that we get,” says Alejandro “Alex” Guerrero, Executive Director of the Macedonia Community Development Corporation.
“Volunteers” tasked with enforcing the Chinese Communist Party’s zero-covid policies have suffered from stress and anxiety, a new study shows.
A new study finds that antibodies produced in the nose decline nine months after COVID-19 infection, while antibodies found in the blood last at least a year.
A brief roundup of news and story ideas from the experts at UCLA Health.
Biodegradable medical gowns, designed to be greener than conventional counterparts, actually produce harmful greenhouse gases, according to new research published Dec. 20 in the Journal of Cleaner Production.
Investigators from the Smidt Heart Institute at Cedars-Sinai have identified how biological pacemaker cells—cells that control your heartbeat—can “fight back” against therapies to biologically correct abnormal heartbeat rates.
New research findings have revealed an underlying genetic cause for why some children who have had COVID-19 infection develop Multisystem Inflammatory Syndrome in Children (MIS-C), a rare but potentially life-threatening disease. The findings, published in Science, are the first potential genetic cause identified for MIS-C, a disease that typically occurs about four weeks after COVID-19 infection and has broad symptoms such as fever, vomiting and inflammation of the heart muscle that can lead to hospitalization. States have reported about 9,000 MIS-C cases, with 71 deaths, according to most recent Centers for Disease Control and Prevention numbers.
Mothers drank alcohol less frequently as the COVID-19 pandemic progressed, according to a small study of Ohio women, but another result was more concerning to researchers.
Perceptions of the causes of illness vary widely across the global population. But now, researchers from Japan have found new information about the perception that individuals with COVID-19 deserved to get infected.
The claim that a blood transfusion could pass on the inoculation from a vaccine is entirely false.
A rehabilitation programme that helps people with long COVID reduce their symptoms and increase activity levels has shown “impressive” results, say scientists.
In one of the first large, real-world studies comparing the effectiveness of COVID-19 vaccines versus natural immunity in protecting against death, hospitalizations and emergency department (ED) visits for any cause, including COVID, research-scientists from Regenstrief Institute, Indiana University School of Medicine and Vanderbilt University Medical Center report that people of all age groups benefited significantly more from vaccination than natural immunity acquired from a previous COVID infection.
The diagnosis and treatment of long COVID syndrome (LCS) is still very difficult, and there is only little knowledge about the factors causing accompanying symptoms.
The incredibly fast spread of COVID-19 throughout the world brought to light a very important fact: we need better methods to diagnose infectious diseases quickly and efficiently.
The paper concludes the COVID Support Our Schools (SOS) program helped underserved communities at a critical time - and its benefits could help with community health outreach beyond the time of a pandemic
Japan’s government has drawn criticism from some of the nation’s researchers following a new analysis that shows Japan has for years been lagging in the field of infectious diseases research, including after the COVID-19 pandemic had hit.
Researchers at UBC’s Life Sciences Institute have identified a compound that shows early promise at halting infections from a range of coronaviruses, including all variants of SARS-CoV-2 and the common cold.
Men are at an increased risk of a severe bout of COVID-19 compared to women.
When patients undergo any type of surgery after having had COVID, their odds of significant postoperative problems diminish with elapsed time from COVID diagnosis. Researchers at Vanderbilt University Medical Center now report that this trend of decreasing risk persists longer than previously known, for as long as 13 months after surgery. Their report appeared Dec. 14 in JAMA Network Open.
Research from the lab of Fangqiong Ling at Washington University in St. Louis showed earlier this year that the amount of SARS-CoV-2 in a wastewater system was correlated with the burden of disease — COVID-19 — in the region it served.
Onset of the COVID-19 pandemic was associated with increased hospitalizations with mental health diagnoses among adolescents, according to the results of this study that included eight children’s hospitals in the United States and France.
Working night shifts is associated with several negative health outcomes, including an increased risk of infections.
Pesquisadores da Mayo Clinic dizem que o anticorpo monoclonal bebtelovimabe (já autorizado pela Food and Drug Administration para uso emergencial na variante ômicron da COVID-19) é uma opção confiável para tratar a BA.2 e outras subvariantes da COVID-19. As descobertas do estudo retrospectivo realizado vários locais, envolvendo 3.607 pacientes de alto risco foram publicadas na revista médica Journal of Infectious Diseases.
Los investigadores de Mayo Clinic informan que el anticuerpo monoclonal bebtelovimab, ya autorizado por la Administración de Alimentos y Medicamentos de Estados Unidos para usar en emergencias de la variante ómicron de la COVID-19, es una alternativa confiable para tratar a la BA.2 y otras subvariantes de la COVID-19. Los resultados del estudio retrospectivo que se realizó en varios sitios con 3607 pacientes de alto riesgo se publicaron en Journal of Infectious Diseases (Revista de Enfermedades Infecciosas).
Researchers trained five classification algorithms to create an accurate model to predict COVID-19 test results. Results identify the key symptom features associated with COVID-19 infection and provide a way for rapid screening and cost effective infection detection. Findings reveal that number of days experiencing symptoms such as fever and difficulty breathing play a large role in COVID-19 test results. Findings also show that molecular tests have much narrower post-symptom onset days compared to post-symptom onset days of serology tests. As a result, the molecular test has the lowest positive rate because it measures current infection.
مدينة روتشستر، ولاية مينيسوتا - يقول باحثو مايو كلينك إن الجسم المضاد أحادي النسيلة ببتيلوفيماب، المُرخص بالفعل من قبل إدارة الغذاء والدواء الأمريكية للاستخدام في حالات الطوارئ الخاصة بمتحور أوميكرون من فيروس كورونا المستجد (كوفيد-19)، هو خيار موثوق لعلاج سلالة BA.2 والمتحورات الفرعية الأخرى لفيروس كورونا المستجد (كوفيد-19). ونتائج دراستهم الاسترجاعية متعددة المواقع والتي شملت 3,607 مريضًا معرضين لمخاطر عالية، منشورة في مجلة الأمراض المعدية.
Reasons underlying hesitancy to get vaccinated against COVID-19 may be associated with increased risks of traffic accidents according to a new study in The American Journal of Medicine, published by Elsevier.
In early 2020, before COVID-19 vaccines and effective treatments were widely available, universal mask wearing was a central strategy for preventing the transmission of COVID-19. But hospitals and other settings with mask mandates faced a challenge.
A retrospective cohort study of more than 44,000 nonhospitalized persons diagnosed with COVID-19 found that nirmatrelvir plus ritonavir reduced the overall risk of hospitalization and death. The study is published in Annals of Internal Medicine.
Last week, China announced that it would roll back its long-standing “zero-COVID-19 policies,” which included constant tests, quarantines and lockdowns. The decision was a dramatic concession following weeks of protests nationwide.The lingering question is what happens next. Will the decision be enough to appease protestors and put an end to President Xi Jinping’s woes? Or, have these protests sparked a new thirst for activism and political change? Below, Zhao Ma, an associate professor of modern Chinese history and culture in Arts & Sciences at Washington University in St.
Investigators from the Smidt Heart Institute at Cedars-Sinai validated the link between a debilitating heart condition and COVID-19 and, to a lesser extent, a novel link between the same condition and COVID-19 vaccination.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
